1. Home
  2. SRV vs EMBC Comparison

SRV vs EMBC Comparison

Compare SRV & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NXG Cushing Midstream Energy Fund of Beneficial Interest

SRV

NXG Cushing Midstream Energy Fund of Beneficial Interest

HOLD

Current Price

$48.46

Market Cap

225.9M

Sector

Finance

ML Signal

HOLD

Logo Embecta Corp.

EMBC

Embecta Corp.

HOLD

Current Price

$3.38

Market Cap

200.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SRV
EMBC
Founded
N/A
1924
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
225.9M
200.5M
IPO Year
2007
2021

Fundamental Metrics

Financial Performance
Metric
SRV
EMBC
Price
$48.46
$3.38
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$18.50
AVG Volume (30 Days)
45.4K
2.8M
Earning Date
01-01-0001
05-05-2026
Dividend Yield
N/A
6.88%
EPS Growth
N/A
20.90
EPS
N/A
0.67
Revenue
N/A
N/A
Revenue This Year
N/A
$1.17
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$5.09
Revenue Growth
N/A
N/A
52 Week Low
$38.11
$2.77
52 Week High
$51.43
$15.55

Technical Indicators

Market Signals
Indicator
SRV
EMBC
Relative Strength Index (RSI) 53.80 29.72
Support Level $48.09 $2.77
Resistance Level $51.06 $9.38
Average True Range (ATR) 1.06 0.21
MACD -0.12 0.23
Stochastic Oscillator 58.32 83.77

Price Performance

Historical Comparison
SRV
EMBC

About SRV NXG Cushing Midstream Energy Fund of Beneficial Interest

NXG Cushing Midstream Energy Fund is a non-diversified, closed-end investment company. Its investment objective is to obtain a high after-tax total return from a combination of capital appreciation and current income. The fund invests at least 80% of its net assets, plus any borrowings for investment purposes, in a portfolio of midstream energy investments.

About EMBC Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

Share on Social Networks: